ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Optimizing Adherence and Glycemia in Youth With New Insulin-Dependent Diabetes Mellitus (IDDM)

This study has been completed.

Sponsored by: Joslin Diabetes Center
Information provided by: Joslin Diabetes Center
ClinicalTrials.gov Identifier: NCT00745342
  Purpose

This 2-year randomized, controlled trial examined the impact of a clinic-based, family teamwork intervention on glycemic control in youth with recently diagnosed type 1 diabetes.


Condition Intervention
Type 1 Diabetes Mellitus
Behavioral: Family Teamwork Intervention

MedlinePlus related topics:   Diabetes    Diabetes Type 1   

Drug Information available for:   Insulin   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title:   Optimizing Adherence and Glycemia in Youth With New IDDM

Further study details as provided by Joslin Diabetes Center:

Primary Outcome Measures:
  • Glycemic control, assessed by hemoglobin A1c [ Time Frame: Every 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Youth quality of life, measured using the youth PedsQL survey and the parent-proxy PedsQL survey [ Time Frame: Annually ] [ Designated as safety issue: No ]
  • Diabetes-specific family conflict, measured using the Diabetes Family Conflict survey (youth and parent versions) [ Time Frame: Annually ] [ Designated as safety issue: No ]
  • Parent involvement in diabetes management tasks, measured using the Diabetes Family Responsibility Questionnaire (youth and parent versions) [ Time Frame: Annually ] [ Designated as safety issue: No ]

Enrollment:   105
Study Start Date:   March 1999
Study Completion Date:   October 2002
Primary Completion Date:   October 2002 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
Teamwork Group: Experimental
Families randomized to the Teamwork Group received the behavioral family teamwork intervention.
Behavioral: Family Teamwork Intervention
Families in the teamwork group received quarterly psychoeducational interventions at regular clinic visits, focusing on promoting family teamwork and reducing diabetes-specific family conflict and diabetes burnout.
Standard Care: No Intervention
Families in the Standard Care group received standard diabetes care and equal attention from study staff between visits to schedule appointments and encourage regular diabetes follow-up care.

  Eligibility
Ages Eligible for Study:   8 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • 8 to 17 years old
  • Duration of type 1 diabetes between 2 months and 6 years
  • Residence in New England or New York
  • At least 1 outpatient visit in the past year

Exclusion Criteria:

  • Major co-morbid psychiatric or medical illness in youth
  • Diagnosis of an active major psychiatric disorder in either parent
  • Diagnosis of a life-threatening medical illness in either parent
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00745342

Locations
United States, Massachusetts
Joslin Diabetes Center    
      Boston, Massachusetts, United States, 02215

Sponsors and Collaborators
Joslin Diabetes Center

Investigators
Principal Investigator:     Lori MB Laffel, MD, MPH     Joslin Diabetes Center    
  More Information


Publications of Results:

Responsible Party:   Joslin Diabetes Center ( Lori M.B. Laffel, MD, MPH )
Study ID Numbers:   92-23, NIH DK-46-887-04
First Received:   August 29, 2008
Last Updated:   September 2, 2008
ClinicalTrials.gov Identifier:   NCT00745342
Health Authority:   United States: Institutional Review Board

Keywords provided by Joslin Diabetes Center:
type 1 diabetes  
glycemic control  
family conflict  
quality of life  
parental involvement  

Study placed in the following topic categories:
Autoimmune Diseases
Metabolic Diseases
Diabetes Mellitus, Type 1
Diabetes Mellitus
Quality of Life
Endocrine System Diseases
Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders
Insulin

Additional relevant MeSH terms:
Immune System Diseases

ClinicalTrials.gov processed this record on October 24, 2008




Links to all studies - primarily for crawlers